NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components

F. Pozzo, T. Bittolo, E. Vendramini, R. Bomben, P. Bulian, F.M. Rossi, A. Zucchetto, E. Tissino, M. Degan, G. D’Arena, F. Di Raimondo, F. Zaja, G. Pozzato, D. Rossi, G. Gaidano, G. Del Poeta, V. Gattei, M. Dal Bo

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

In chronic lymphocytic leukemia (CLL), the mechanisms controlling cell growth and proliferation in the presence of NOTCH1 mutations remain largely unexplored. By performing a gene expression profile of NOTCH1-mutated (NOTCH1-mut) versus NOTCH1 wild-type CLL, we identified a gene signature of NOTCH1-mut CLL characterized by the upregulation of genes related to ribosome biogenesis, such as nucleophosmin 1 (NPM1) and ribosomal proteins (RNPs). Activation of NOTCH1 signaling by ethylenediaminetetraacetic acid or by coculture with JAGGED1-expressing stromal cells increased NPM1 expression, and inhibition of NOTCH1 signaling by either NOTCH1-specific small interfering RNA (siRNA) or γ-secretase inhibitor reduced NPM1 expression. Bioinformatic analyses and in vitro activation/inhibition of NOTCH1 signaling suggested a role of MYC as a mediator of NOTCH1 effects over NPM1 and RNP expression in NOTCH1-mut CLL. Chromatin immunoprecipitation experiments performed on NOTCH1 intracellular domain (NICD)-transfected CLL-like cells showed the direct binding of NOTCH1 to the MYC promoter, and transfection with MYC-specific siRNA reduced NPM1 expression. In turn, NPM1 determined a proliferation advantage of CLL-like cells, as demonstrated by NPM1-specific siRNA transfection. In conclusion, NOTCH1 mutations in CLL are associated with the overexpression of MYC and MYC-related genes involved in protein biosynthesis including NPM1, which are allegedly responsible for cell growth and/or proliferation advantages of NOTCH1-mut CLL.Leukemia advance online publication, 18 April 2017; doi:10.1038/leu.2017.90. © 2017 Macmillan Publishers Limited, part of Springer Nature.
Original languageEnglish
Pages (from-to)2407-2415
Number of pages9
JournalLeukemia
Volume31
Issue number11
DOIs
Publication statusPublished - 2017

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Ribosomes
Small Interfering RNA
Transfection
Genes
Amyloid Precursor Protein Secretases
Mutation
nucleophosmin
Chromatin Immunoprecipitation
Ribosomal Proteins
Protein Biosynthesis
Stromal Cells
Growth
Coculture Techniques
Computational Biology
Transcriptome
Edetic Acid
Publications
Leukemia
Up-Regulation

Keywords

  • NOTCH1 protein, human
  • Notch1 receptor
  • nuclear protein
  • nucleophosmin
  • cell proliferation
  • chronic lymphatic leukemia
  • coculture
  • genetics
  • human
  • metabolism
  • mutation
  • oncogene myc
  • pathology
  • ribosome
  • signal transduction
  • tumor cell culture
  • upregulation
  • Cell Proliferation
  • Coculture Techniques
  • Genes, myc
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Mutation
  • Nuclear Proteins
  • Receptor, Notch1
  • Ribosomes
  • Signal Transduction
  • Tumor Cells, Cultured
  • Up-Regulation

Cite this

NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components. / Pozzo, F.; Bittolo, T.; Vendramini, E.; Bomben, R.; Bulian, P.; Rossi, F.M.; Zucchetto, A.; Tissino, E.; Degan, M.; D’Arena, G.; Di Raimondo, F.; Zaja, F.; Pozzato, G.; Rossi, D.; Gaidano, G.; Del Poeta, G.; Gattei, V.; Dal Bo, M.

In: Leukemia, Vol. 31, No. 11, 2017, p. 2407-2415.

Research output: Contribution to journalArticle

Pozzo, F, Bittolo, T, Vendramini, E, Bomben, R, Bulian, P, Rossi, FM, Zucchetto, A, Tissino, E, Degan, M, D’Arena, G, Di Raimondo, F, Zaja, F, Pozzato, G, Rossi, D, Gaidano, G, Del Poeta, G, Gattei, V & Dal Bo, M 2017, 'NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components', Leukemia, vol. 31, no. 11, pp. 2407-2415. https://doi.org/10.1038/leu.2017.90
Pozzo, F. ; Bittolo, T. ; Vendramini, E. ; Bomben, R. ; Bulian, P. ; Rossi, F.M. ; Zucchetto, A. ; Tissino, E. ; Degan, M. ; D’Arena, G. ; Di Raimondo, F. ; Zaja, F. ; Pozzato, G. ; Rossi, D. ; Gaidano, G. ; Del Poeta, G. ; Gattei, V. ; Dal Bo, M. / NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components. In: Leukemia. 2017 ; Vol. 31, No. 11. pp. 2407-2415.
@article{44fa4cdff91d460783844bed4b1ba139,
title = "NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components",
abstract = "In chronic lymphocytic leukemia (CLL), the mechanisms controlling cell growth and proliferation in the presence of NOTCH1 mutations remain largely unexplored. By performing a gene expression profile of NOTCH1-mutated (NOTCH1-mut) versus NOTCH1 wild-type CLL, we identified a gene signature of NOTCH1-mut CLL characterized by the upregulation of genes related to ribosome biogenesis, such as nucleophosmin 1 (NPM1) and ribosomal proteins (RNPs). Activation of NOTCH1 signaling by ethylenediaminetetraacetic acid or by coculture with JAGGED1-expressing stromal cells increased NPM1 expression, and inhibition of NOTCH1 signaling by either NOTCH1-specific small interfering RNA (siRNA) or γ-secretase inhibitor reduced NPM1 expression. Bioinformatic analyses and in vitro activation/inhibition of NOTCH1 signaling suggested a role of MYC as a mediator of NOTCH1 effects over NPM1 and RNP expression in NOTCH1-mut CLL. Chromatin immunoprecipitation experiments performed on NOTCH1 intracellular domain (NICD)-transfected CLL-like cells showed the direct binding of NOTCH1 to the MYC promoter, and transfection with MYC-specific siRNA reduced NPM1 expression. In turn, NPM1 determined a proliferation advantage of CLL-like cells, as demonstrated by NPM1-specific siRNA transfection. In conclusion, NOTCH1 mutations in CLL are associated with the overexpression of MYC and MYC-related genes involved in protein biosynthesis including NPM1, which are allegedly responsible for cell growth and/or proliferation advantages of NOTCH1-mut CLL.Leukemia advance online publication, 18 April 2017; doi:10.1038/leu.2017.90. {\circledC} 2017 Macmillan Publishers Limited, part of Springer Nature.",
keywords = "NOTCH1 protein, human, Notch1 receptor, nuclear protein, nucleophosmin, cell proliferation, chronic lymphatic leukemia, coculture, genetics, human, metabolism, mutation, oncogene myc, pathology, ribosome, signal transduction, tumor cell culture, upregulation, Cell Proliferation, Coculture Techniques, Genes, myc, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Mutation, Nuclear Proteins, Receptor, Notch1, Ribosomes, Signal Transduction, Tumor Cells, Cultured, Up-Regulation",
author = "F. Pozzo and T. Bittolo and E. Vendramini and R. Bomben and P. Bulian and F.M. Rossi and A. Zucchetto and E. Tissino and M. Degan and G. D’Arena and {Di Raimondo}, F. and F. Zaja and G. Pozzato and D. Rossi and G. Gaidano and {Del Poeta}, G. and V. Gattei and {Dal Bo}, M.",
note = "Cited By :3 Export Date: 21 February 2018 Article in Press CODEN: LEUKE Correspondence Address: Pozzo, F.",
year = "2017",
doi = "10.1038/leu.2017.90",
language = "English",
volume = "31",
pages = "2407--2415",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components

AU - Pozzo, F.

AU - Bittolo, T.

AU - Vendramini, E.

AU - Bomben, R.

AU - Bulian, P.

AU - Rossi, F.M.

AU - Zucchetto, A.

AU - Tissino, E.

AU - Degan, M.

AU - D’Arena, G.

AU - Di Raimondo, F.

AU - Zaja, F.

AU - Pozzato, G.

AU - Rossi, D.

AU - Gaidano, G.

AU - Del Poeta, G.

AU - Gattei, V.

AU - Dal Bo, M.

N1 - Cited By :3 Export Date: 21 February 2018 Article in Press CODEN: LEUKE Correspondence Address: Pozzo, F.

PY - 2017

Y1 - 2017

N2 - In chronic lymphocytic leukemia (CLL), the mechanisms controlling cell growth and proliferation in the presence of NOTCH1 mutations remain largely unexplored. By performing a gene expression profile of NOTCH1-mutated (NOTCH1-mut) versus NOTCH1 wild-type CLL, we identified a gene signature of NOTCH1-mut CLL characterized by the upregulation of genes related to ribosome biogenesis, such as nucleophosmin 1 (NPM1) and ribosomal proteins (RNPs). Activation of NOTCH1 signaling by ethylenediaminetetraacetic acid or by coculture with JAGGED1-expressing stromal cells increased NPM1 expression, and inhibition of NOTCH1 signaling by either NOTCH1-specific small interfering RNA (siRNA) or γ-secretase inhibitor reduced NPM1 expression. Bioinformatic analyses and in vitro activation/inhibition of NOTCH1 signaling suggested a role of MYC as a mediator of NOTCH1 effects over NPM1 and RNP expression in NOTCH1-mut CLL. Chromatin immunoprecipitation experiments performed on NOTCH1 intracellular domain (NICD)-transfected CLL-like cells showed the direct binding of NOTCH1 to the MYC promoter, and transfection with MYC-specific siRNA reduced NPM1 expression. In turn, NPM1 determined a proliferation advantage of CLL-like cells, as demonstrated by NPM1-specific siRNA transfection. In conclusion, NOTCH1 mutations in CLL are associated with the overexpression of MYC and MYC-related genes involved in protein biosynthesis including NPM1, which are allegedly responsible for cell growth and/or proliferation advantages of NOTCH1-mut CLL.Leukemia advance online publication, 18 April 2017; doi:10.1038/leu.2017.90. © 2017 Macmillan Publishers Limited, part of Springer Nature.

AB - In chronic lymphocytic leukemia (CLL), the mechanisms controlling cell growth and proliferation in the presence of NOTCH1 mutations remain largely unexplored. By performing a gene expression profile of NOTCH1-mutated (NOTCH1-mut) versus NOTCH1 wild-type CLL, we identified a gene signature of NOTCH1-mut CLL characterized by the upregulation of genes related to ribosome biogenesis, such as nucleophosmin 1 (NPM1) and ribosomal proteins (RNPs). Activation of NOTCH1 signaling by ethylenediaminetetraacetic acid or by coculture with JAGGED1-expressing stromal cells increased NPM1 expression, and inhibition of NOTCH1 signaling by either NOTCH1-specific small interfering RNA (siRNA) or γ-secretase inhibitor reduced NPM1 expression. Bioinformatic analyses and in vitro activation/inhibition of NOTCH1 signaling suggested a role of MYC as a mediator of NOTCH1 effects over NPM1 and RNP expression in NOTCH1-mut CLL. Chromatin immunoprecipitation experiments performed on NOTCH1 intracellular domain (NICD)-transfected CLL-like cells showed the direct binding of NOTCH1 to the MYC promoter, and transfection with MYC-specific siRNA reduced NPM1 expression. In turn, NPM1 determined a proliferation advantage of CLL-like cells, as demonstrated by NPM1-specific siRNA transfection. In conclusion, NOTCH1 mutations in CLL are associated with the overexpression of MYC and MYC-related genes involved in protein biosynthesis including NPM1, which are allegedly responsible for cell growth and/or proliferation advantages of NOTCH1-mut CLL.Leukemia advance online publication, 18 April 2017; doi:10.1038/leu.2017.90. © 2017 Macmillan Publishers Limited, part of Springer Nature.

KW - NOTCH1 protein, human

KW - Notch1 receptor

KW - nuclear protein

KW - nucleophosmin

KW - cell proliferation

KW - chronic lymphatic leukemia

KW - coculture

KW - genetics

KW - human

KW - metabolism

KW - mutation

KW - oncogene myc

KW - pathology

KW - ribosome

KW - signal transduction

KW - tumor cell culture

KW - upregulation

KW - Cell Proliferation

KW - Coculture Techniques

KW - Genes, myc

KW - Humans

KW - Leukemia, Lymphocytic, Chronic, B-Cell

KW - Mutation

KW - Nuclear Proteins

KW - Receptor, Notch1

KW - Ribosomes

KW - Signal Transduction

KW - Tumor Cells, Cultured

KW - Up-Regulation

U2 - 10.1038/leu.2017.90

DO - 10.1038/leu.2017.90

M3 - Article

VL - 31

SP - 2407

EP - 2415

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 11

ER -